-
Comparative analysis of immune infiltrates in head and neck cancers across anatomical sites
Muijlwijk, T., Nijenhuis, D. N. L. M., Ganzevles, S. H., Brink, A., Ke, C., Fass, J. N., Rajamanickam, V., Leemans, C. R., Koguchi, Y., Fox, B. A., Poell, J. B., Brakenhoff, R. H. & van de Ven, R., 11 Jan 2024, In: Journal for Immunotherapy of Cancer. 12, 1, e007573.Research output: Contribution to journal › Article › Academic › peer-review
-
An antibody-drug conjugate directed to tissue factor shows preclinical anti-tumor activity in head and neck cancer as a single agent and in combination with chemoradiotherapy
Bakema, J. E., van Walsum, M. S., Harris, J. R., Ganzevles, S. H., Muthuswamy, A., Houtkamp, M., Plantinga, T. S., Bloemena, E., Brakenhoff, R. H., Breij, E. C. W. & van de Ven, R., 12 Oct 2023, (E-pub ahead of print) In: Molecular Cancer Therapeutics.Research output: Contribution to journal › Article › Academic › peer-review
-
Nk cell-dependent antibody-mediated immunotherapy is improved in vitro and in vivo when combined with agonists for toll-like receptor 2 in head and neck cancer models
Gruijs, M., Ganzevles, S. H., Stigter-Van Walsum, M., van der Mast, R., van Ostaijen-Ten Dam, M. M., Tuk, C. W., Schilham, M. W., Leemans, C. R., Brakenhoff, R. H., van Egmond, M., van de Ven, R. & Bakema, J. E., 1 Oct 2021, In: International journal of molecular sciences. 22, 20, 11057.Research output: Contribution to journal › Article › Academic › peer-review
- All publications
